Xenon Pharmaceuticals (XENE) Return on Invested Capital (2018 - 2020)

Xenon Pharmaceuticals (XENE) has 3 years of Return on Invested Capital data on file, last reported at 0.01% in Q4 2020.

• On a quarterly basis, Return on Invested Capital fell 1.0% year-over-year to 0.01% in Q4 2020; TTM through Dec 2020 was 0.01%, a 1.0% decrease from a year earlier, with the FY2019 full-year figure at 0.02%, up 1.0% from the prior year.
• Return on Invested Capital for Q4 2020 stood at 0.01%, down from 0.0% in the prior quarter.
• Over the last five years, Return on Invested Capital for XENE reached as high as 0.0% in Q2 2020 and fell as low as 0.02% in Q4 2018.
• Historically, Return on Invested Capital has averaged 0.01% across 3 years, with a median of 0.01% in 2019.
• Across the five-year window, Return on Invested Capital grew 2 bps in 2019 and fell 1 bps in 2020, its largest moves.
• Year by year, Return on Invested Capital stood at 0.02% in 2018, then jumped by 76 bps to 0.01% in 2019, then sank by 163 bps to 0.01% in 2020.
• Per Business Quant data, the three most recent Return on Invested Capital figures were 0.01% in Q4 2020, 0.0% in Q3 2020, and 0.0% in Q2 2020.